Financial Ratios

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE689.454.9 (+0.72 %)
PREV CLOSE ( ) 684.55
OPEN PRICE ( ) 693.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 331779
TODAY'S LOW / HIGH ( )679.70 700.00
52 WK LOW / HIGH ( )597.95 977.45
NSE687.852.8 (+0.41 %)
PREV CLOSE( ) 685.05
OPEN PRICE ( ) 687.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 687.85 (224)
VOLUME 401862
TODAY'S LOW / HIGH( ) 678.45 700.00
52 WK LOW / HIGH ( )598.6 978
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.460.47-191.23-1282.16-132.42
   CEPS(Rs)1.750.86-32.38-110.14-11.19
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)93.1192.3210464.8419943.979102.47
   Tax Rate(%)26.920.000.00-2.110.00
Margin Ratios
   Core EBITDA Margin(%)2.712.12-12.58-40.67-36.44
   EBIT Margin(%)6.125.26-11.44-38.92-26.99
   Pre Tax Margin(%)3.293.58-12.25-39.35-26.99
   PAT Margin (%)2.403.58-12.25-40.18-26.99
   Cash Profit Margin (%)9.036.55-10.37-38.83-25.66
Performance Ratios
   ROA(%)0.450.64-1.78-8.19-1.35
   ROE(%)0.500.71-2.00-8.83-1.44
   ROCE(%)1.251.01-1.75-8.30-1.39
   Asset Turnover(x)0.190.180.150.200.05
   Sales/Fixed Asset(x)1.572.633.9811.745.66
   Working Capital/Sales(x)2.250.250.847.09-2.93
Efficiency Ratios
   Fixed Capital/Sales(x)0.640.380.250.090.18
   Receivable days46.5638.3852.4631.4850.51
   Inventory Days8.3710.1622.7612.287.15
   Payable days21.3112.1512.6126.74
Valuation Parameters
   PER(x)1401.232160.500.000.000.00
   PCE(x)372.571180.320.000.000.00
   Price/Book(x)6.9910.940.000.000.00
   Yield(%)0.000.00
   EV/Net Sales(x)35.8982.66-1.26-0.17-0.04
   EV/Core EBITDA(x)260.83937.9312.900.450.14
   EV/EBIT(x)543.371467.0910.780.440.13
   EV/CE(x)6.0310.14-0.16-0.030.00
   M Cap / Sales36.3182.710.000.000.00
Growth Ratio
   Net Sales Growth(%)46.81113.3111.78541.941.03
   Core EBITDA Growth(%)129.23292.0471.25-851.9432.31
   EBIT Growth(%)72.12202.6066.79-837.8031.80
   PAT Growth(%)-0.63165.1265.56-868.2484.11
   EPS Growth(%)-0.62100.2485.09-868.2484.11
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)3.1420.374.511.540.47
   Quick Ratio(x)3.0020.254.311.300.44
   Interest Cover(x)2.163.12-14.16-89.56
   Total Debt/Mcap(x)0.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.